Four weeks after LFBV, intervention group had significantly lower urinary leukocytes, postvoid residual volume, fewer signs and symptoms of UTI. (HealthDay News) — Applying low-frequency bladder ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...